Lorenza Landi

5PUBLICATIONS
162CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 14, 2026
Second- and third-line outcomes after selective RET inhibitor failure in RET fusion-positive metastatic lung cancer: A real-world analysis from the RET-MAP registry.

|Jul 14, 2026
Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer Receiving First-line Osimertinib.

|May 18, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.

|Jan 21, 2025
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial.

Federico Cappuzzo, Biagio Ricciuti, Angelo Delmonte

|Apr 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.

Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti

Pageof 1

Frequent Collaborators

5 joint publications

Biagio Ricciuti

4 joint publications

Federico Cappuzzo

4 joint publications

Mark Magdi Awad

3 joint publications

Julia Rotow